These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9720959)

  • 21. Deficient resistance to Coccidioides immitis following intravenous vaccination. 3. Humoral and cellular responses to intravenous and intramuscular doses.
    Levine HB; Scalarone GM
    Sabouraudia; 1971 Jul; 9(2):97-108. PubMed ID: 5111563
    [No Abstract]   [Full Text] [Related]  

  • 22. Coccidioides immitis antigen.
    Pappagianis D
    J Infect Dis; 1999 Jul; 180(1):243-4. PubMed ID: 10353891
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune responses in coccidioidomycosis.
    Levine HB
    Mykosen Suppl; 1978; 1():280-4. PubMed ID: 299487
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccinated C57BL/6 mice develop protective and memory T cell responses to Coccidioides posadasii infection in the absence of interleukin-10.
    Hung CY; Castro-Lopez N; Cole GT
    Infect Immun; 2014 Feb; 82(2):903-13. PubMed ID: 24478103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
    Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
    Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficient resistance to Coccidioides immitis following intravenous vaccination. II. Evidence against an immune tolerance mechanism.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):90-6. PubMed ID: 4939207
    [No Abstract]   [Full Text] [Related]  

  • 27. Deficient resistance to Coccidioides immitis following intravenous vaccination. I. Distribution of spherules after intravenous and intramuscular doses.
    Scalarone GM; Levine HB
    Sabouraudia; 1971 Jul; 9(2):81-9. PubMed ID: 5111562
    [No Abstract]   [Full Text] [Related]  

  • 28. Seeking a vaccine against Coccidioides immitis and serologic studies: expectations and realities.
    Pappagianis D
    Fungal Genet Biol; 2001 Feb; 32(1):1-9. PubMed ID: 11277621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular responses in lungs of immunized mice to intranasal infection with Coccidioides immitis.
    Savage DC; Madin SH
    Sabouraudia; 1968 Feb; 6(2):94-102. PubMed ID: 5647153
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.
    Jiang C; Magee DM; Ivey FD; Cox RA
    Infect Immun; 2002 Jul; 70(7):3539-45. PubMed ID: 12065493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spherulin as a complement-fixing antigen in human coccidioidomycosis.
    Scalarone GM; Levine HB; Pappagianis D; Chaparas SD
    Am Rev Respir Dis; 1974 Sep; 110(3):324-8. PubMed ID: 4213393
    [No Abstract]   [Full Text] [Related]  

  • 32. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
    Hung CY; Wozniak KL; Cole GT
    Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intranasal Antifungal Vaccination Using DNA-Transfected Dendritic Cells.
    Awasthi S
    Methods Mol Biol; 2017; 1625():75-83. PubMed ID: 28584984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
    Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
    J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.
    Li K; Yu JJ; Hung CY; Lehmann PF; Cole GT
    Infect Immun; 2001 May; 69(5):2878-87. PubMed ID: 11292702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A recombinant beta-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis.
    Delgado N; Xue J; Yu JJ; Hung CY; Cole GT
    Infect Immun; 2003 Jun; 71(6):3010-9. PubMed ID: 12761077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of B cells in vaccine-induced immunity against coccidioidomycosis.
    Magee DM; Friedberg RL; Woitaske MD; Johnston SA; Cox RA
    Infect Immun; 2005 Oct; 73(10):7011-3. PubMed ID: 16177382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization of mice with induced mutants of Coccidioides immitis. I. Characterization of mutants and preliminary studies of their use as viable vaccines.
    Walch HA; Kalvoda A
    Sabouraudia; 1971 Nov; 9(3):173-84. PubMed ID: 5135085
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of coccidioidomycosis diagnosed by exoantigen testing.
    Huber TW; Burrows KR; Steadham JE
    Diagn Microbiol Infect Dis; 1985 Sep; 3(5):445-50. PubMed ID: 3928239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attributes of deficient immunity in mice receiving Coccidioides immitis Spherule vaccine by the intravenous route.
    Scalarone GM; Levine HB
    Sabouraudia; 1969 Oct; 7(3):169-77. PubMed ID: 5385153
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.